PICTET ASSET MANAGEMENT LTD - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT LTD ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q1 2021$3,741,000
-46.6%
110,267
-49.9%
0.00%
-55.6%
Q4 2020$7,003,000
+19.5%
220,234
-3.5%
0.01%0.0%
Q3 2020$5,859,000
+7.5%
228,334
+7.6%
0.01%0.0%
Q2 2020$5,448,000
+50.2%
212,224
-10.0%
0.01%
+12.5%
Q1 2020$3,626,000
-28.0%
235,924
+60.7%
0.01%
-11.1%
Q4 2019$5,038,000
+130.9%
146,824
-49.7%
0.01%
+350.0%
Q3 2019$2,182,000
+22.2%
292,048
+112.4%
0.00%
-50.0%
Q2 2019$1,785,000
+4.6%
137,524
-1.8%
0.00%0.0%
Q1 2019$1,706,000
+55.4%
140,100
+45.3%
0.00%
+33.3%
Q4 2018$1,098,000
-32.2%
96,400
+29.2%
0.00%0.0%
Q3 2018$1,619,000
+22.8%
74,6000.0%0.00%0.0%
Q2 2018$1,318,000
-9.9%
74,600
+7.3%
0.00%
-25.0%
Q1 2018$1,463,000
-29.0%
69,500
-45.2%
0.00%
-42.9%
Q1 2017$2,062,000
+11.0%
126,864
+3.1%
0.01%0.0%
Q4 2016$1,858,000
+13.2%
123,108
+14.4%
0.01%
+16.7%
Q3 2016$1,641,000107,6480.01%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2016
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders